Effects of the addition of second‐messenger effectors to platelet concentrates separated from whole‐blood donations and stored at 4°C or –80°C
- 1 May 2000
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 40 (5) , 527-534
- https://doi.org/10.1046/j.1537-2995.2000.40050527.x
Abstract
BACKGROUND: Platelet concentrates (PCs) are currently stored at 22°C under continuous agitation. Because of the potential risk of the overgrowth of bacteria in case of contamination, PC shelf life is limited to 5 days. A mixture of second-messenger effectors is being evaluated to determine if it has benefits for cold liquid storage and cryopreservation of platelets. STUDY DESIGN AND METHODS: PCs separated from whole-blood donations by the buffy coat method were randomly assigned (n = 6 each) to be stored for 5 days at 22°C under continuous agitation or at 4°C after treatment with a platelet storage medium (ThromboSol, LifeCell Corp.). PCs were also cryopreserved with 6-percent DMSO (final concentration) or with ThromboSol plus 2-percent DMSO (final concentration) (TC). After storage, platelets were analyzed by flow cytometry, transmission electron microscopy, and aggregation and perfusion techniques. RESULTS: Cold liquid storage of ThromboSol-treated platelets resulted in a lower binding of coagulation factor Va on the platelet surface than on platelets stored at 22°C. In transmission electron microscopy, a conversion to spherical morphology was seen in the case of cold liquid storage. No difference between ThromboSol-treated platelets stored at 4°C and platelets stored at 22°C was seen in perfusion studies. Cryopreservation in the presence of TC prevented the reduction in glycoprotein Ib and IV expression on platelet surface that is seen in 6-percent DMSO-cryopreserved platelets. Platelets cryopreserved in TC covered, by thrombus, a significantly greater percentage of the perfused surface after the freezing and thawing process. CONCLUSION: ThromboSol-treated PCs separated from whole-blood donations by the buffy coat method, stored at 4°C for 5 days, or cryopreserved in the presence of TC, maintained in vitro functional activity comparable to that achieved by current methods of storage, although discoid morphology was not preserved during cold liquid storage with ThromboSol.Keywords
This publication has 22 references indexed in Scilit:
- Quality assessment of platelet concentrates supplemented with second‐messenger effectorsTransfusion, 1999
- Cryopreservation of single‐donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second‐messenger effectors: enhanced retention of in vitro functional activityTransfusion, 1998
- The platelet storage lesionTransfusion Medicine Reviews, 1997
- Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4° C with retention of in vitro functional activityTransfusion, 1997
- Recovery of in vitro functional activity of platelet concentrates stored at 4 ° C and treated with second‐messenger effectorsTransfusion, 1996
- Platelet concentrates promote procoagulant activity: evidence from experimental studies using a perfusion techniqueTransfusion, 1995
- Platelet activation during preparation of platelet concentrates: a comparison of the platelet‐rich plasma and the buffy coat methodsTransfusion, 1990
- Platelet membrane glycoprotein changes during the preparation and storage of platelet concentratesTransfusion, 1988
- Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperatureTransfusion, 1986
- Changes in membrane phospholipid distribution during platelet activationBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983